Cannabis Suisse Swings to $63,207 Profit in Nine Months Ending February 2026

Cannabis Suisse Corp., a company that generates revenue from rental properties, reported net income of $63,207 for the nine months ending February 28, 2026, a sharp reversal from a net loss of $500,509 in the same period a year earlier. Read more earnings reports.

For the three months ending February 28, 2026, the company posted net income of $26,908, compared to $29,515 in the year-ago quarter. Rental income for the nine-month period totaled $22,500, down from rental income in prior periods, while cost of goods sold was $22,068, leaving a gross profit of $432.

Operating expenses for the nine months fell to $228,909 from $234,368 a year earlier. Professional fees declined to $41,720 from $65,547, while general and administrative expenses rose to $184,006 from $165,638. The company recorded $3,183 in depreciation for both periods.

The company's operating loss for the nine months narrowed to $228,909 from $233,936. However, other income totaled $292,116 for the nine months ending February 2026, compared to other expenses of $266,573 in the prior-year period. The swing was driven by amortization of debt premium totaling $340,475, partially offset by interest expense to related parties of $48,359.

In the prior-year period, the company recorded a loss on settlement of debt of $551,677, which contributed to the year-ago net loss.

Balance Sheet Contraction

Total assets declined to $455,714 as of February 28, 2026, from $635,075 at May 31, 2025. Cash in escrow fell to $75 from $2,850, while prepaid expenses dropped to $65,708 from $103,991. Operating lease right-of-use assets decreased to $372,746 from $507,866.

Total liabilities declined to $2,194,479 from $2,437,047. Current liabilities rose to $423,427 from $325,520, driven by an increase in accrued interest to related parties, which climbed to $106,567 from $58,208. Advances from related parties rose to $66,350 from $19,400.

The company's stockholders' deficit narrowed to $1,738,765 from $1,801,972 as accumulated losses decreased to $2,993,839 from $3,057,046. The company has 70,680,938 common shares outstanding and 5,000,000 Series A preferred shares outstanding as of February 28, 2026.

Cash Flow and Financing

Cash used in operating activities for the nine months totaled $49,725, compared to $35,912 in the prior-year period. The company received $46,950 in advances from related parties during the nine months, compared to $7,400 in the year-ago period after accounting for repayments.

Cash at the end of the period stood at $75, down from $2,850 at May 31, 2025. The company reported no cash paid for taxes or interest during the nine-month period.

Financial Summary